BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 16831226)

  • 21. Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-γ-linolenic acid peroxidation dependent mechanism.
    Xu Y; Yang X; Wang T; Yang L; He YY; Miskimins K; Qian SY
    BMC Cancer; 2018 Mar; 18(1):330. PubMed ID: 29587668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases.
    Yun EJ; Song KS; Shin S; Kim S; Heo JY; Kweon GR; Wu T; Park JI; Lim K
    Oncotarget; 2016 Aug; 7(31):49961-49971. PubMed ID: 27363023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44.
    Kinugasa Y; Hatori M; Ito H; Kurihara Y; Ito D; Nagumo M
    Clin Exp Metastasis; 2004; 21(8):737-45. PubMed ID: 16035618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropins induce tumor cell migration and invasion by increasing cyclooxygenases expression and prostaglandin E(2) production in human ovarian cancer cells.
    Lau MT; Wong AS; Leung PC
    Endocrinology; 2010 Jul; 151(7):2985-93. PubMed ID: 20392831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
    Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
    Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumor effect and mechanism of cyclooxygenase-2 inhibitor through matrix metalloproteinase 14 pathway in PANC-1 cells.
    Li S; Gu Z; Xiao Z; Zhou T; Li J; Sun K
    Int J Clin Exp Pathol; 2015; 8(2):1737-42. PubMed ID: 25973062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output.
    Miller ME; Holloway AC; Foster WG
    Clin Exp Metastasis; 2005; 22(2):149-56. PubMed ID: 16086235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells.
    Park SY; Kim YH; Kim Y; Lee SJ
    J Cell Biochem; 2012 Dec; 113(12):3653-62. PubMed ID: 22740037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer.
    Zhang H; Sun K; Ding J; Xu H; Zhu L; Zhang K; Li X; Sun W
    Phytomedicine; 2014 Feb; 21(3):348-55. PubMed ID: 24176842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of COX-2 by RNAi modulates epithelial-mesenchymal transition in breast cancer cells partially dependent on the PGE2 cascade.
    Cao J; Yang X; Li WT; Zhao CL; Lv SJ
    Asian Pac J Cancer Prev; 2014; 15(22):9967-72. PubMed ID: 25520137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cyclooxygenase 2 in human malignant melanoma.
    Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S
    Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells.
    Hwang ES; Park KK
    Biosci Biotechnol Biochem; 2010; 74(5):961-7. PubMed ID: 20460721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells.
    Horia E; Watkins BA
    Carcinogenesis; 2007 Apr; 28(4):809-15. PubMed ID: 17052999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment of breast cancer cell lines with vitamin D and COX-2 inhibitors.
    Thill M; Reichert K; Woeste A; Polack S; Fischer D; Hoellen F; Rody A; Friedrich M; Köster F
    Anticancer Res; 2015 Feb; 35(2):1189-95. PubMed ID: 25667510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sanguinarine inhibits invasiveness and the MMP-9 and COX-2 expression in TPA-induced breast cancer cells by inducing HO-1 expression.
    Park SY; Jin ML; Kim YH; Lee SJ; Park G
    Oncol Rep; 2014 Jan; 31(1):497-504. PubMed ID: 24220687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism.
    Hinz B; Rösch S; Ramer R; Tamm ER; Brune K
    FASEB J; 2005 Nov; 19(13):1929-31. PubMed ID: 16076963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
    Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
    J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
    Haupt LM; Thompson EW; Trezise AE; Irving RE; Irving MG; Griffiths LR
    BMC Cancer; 2006 Jan; 6():18. PubMed ID: 16430785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells.
    Simeone AM; Nieves-Alicea R; McMurtry VC; Colella S; Krahe R; Tari AM
    Int J Oncol; 2007 Apr; 30(4):785-92. PubMed ID: 17332916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.